Diabetes mellitus as a prothrombotic condition
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bini A, 1987, Immunohistochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions, Blood, 69, 1038, 10.1182/blood.V69.4.1038.1038
Lind S, 2003, Blood. Principles and Practice of Hematology, 959
Juhan‐Vague I, 1989, Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients. Relationship with plasma insulin, Thromb Haemost, 61, 370, 10.1055/s-0038-1646598
Mansfield M, 1997, PAI‐1 concentrations in first degree relatives of patients with non‐insulin dependent diabetes: metabolic and genetic associations, Thromb Haemost, 77, 357, 10.1055/s-0038-1655968
Kruithof E, 1988, Plasminogen activator inhibitor type 1: biochemical, biological and clinical aspects, Fibrinolysis, 2, 59
Juhan‐Vague I, 1987, Relationships between plasma insulin, triglyceride, body mass index and plasminogen activator inhibitor 1, Diab Metab, 13, 331
Vague P, 1987, Metformin decreased the high plasminogen activator inhibitor capacity, plasma insulin and triglycerides in non diabetic obese subjects, Thromb Haemost, 57, 326, 10.1055/s-0038-1651126
Kooistra T, 1989, Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes, Thromb Haemost, 62, 723, 10.1055/s-0038-1646891
Padayattay S, 1993, The effects of insulin‐like growth factor‐1 on plasminogen activator inhibitor 1 synthesis and secretion: results from in vitro and in vivo studies, Thromb Haemost, 70, 1009, 10.1055/s-0038-1649716
Carter A, 1998, Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease, Thromb Haemost, 80, 632
Scarabin P‐Y, 1998, Associations of fibrinogen, factor VII and PAI‐1 with baseline findings among 10500 male participants in a prospective study of myocardial infarction. The Prime Study, Thromb Haemost, 80, 749, 10.1055/s-0037-1615353
Balleisen L, 1985, Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population – I. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill using, and menopause, Thromb Haemost, 54, 475, 10.1055/s-0038-1657877
Balleisen L, 1985, Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population – II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions, Thromb Haemost, 54, 721, 10.1055/s-0038-1660106
Heywood D, 1996, Factor VII gene polymorphisms, factor VIIc levels and features of insulin resistance in non‐insulin dependent diabetes mellitus, Thromb Haemost, 75, 401, 10.1055/s-0038-1650286
Krolewski A, 1981, Prevalence of diabetes mellitus, coronary heart disease and hypertension in the families of insulin dependent and insulin independent diabetes, Diabetologia, 21, 520, 10.1007/BF00281541
Carvalho de Sousa J, 1989, Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity, Haemostasis, 19, 125
Carvalho A, 1978, Activation of the kallikrein system in hyperbetalipoproteinemia, J Lab Clin Med, 91, 117
Blann A, 1991, Increased circulating levels of von Willebrand Factor antigen in smokers may be due to lipid peroxides, Med Sci Res, 19, 535
Blann A, 1993, von Willebrand factor and endothelial damage in essential hypertension, J Hum Hypertens, 7, 107
Conlan M, 1993, Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities Study, Thromb Haemost, 70, 380, 10.1055/s-0038-1649589
Lowe G, 1980, Increased plasma fibrinogen and platelet aggregates in type II hyperlipoproteinaemia, Thromb Haemost, 42, 1503
Korsan‐Bengtsen K, 1972, Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. Relations of the variables to ‘risk factors’ for myocardial infarction, Thromb Diath Haemorrh, 28, 99
Avellone G, 1994, Blood coagulation and fibrinolysis in obese NIDDM patients, Diabetes Res, 25, 85
Collier A, 1992, Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria, Diabetes, 41, 909, 10.2337/diab.41.8.909
Christe M, 1984, Fifteen coagulation factors and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy, Thromb Haemost, 52, 138, 10.1055/s-0038-1661158
Jain A, 2001, Hyperfibrinogenaemia in patients of diabetes mellitus in relation to glycaemic control and urinary albumin excretion rate, J Assoc Physicians India, 49, 225
Reid H, 2000, The influence of persistent hyperglycaemia on hyperfibrinogenaemia and hyperviscosity in diabetes mellitus, West Indian Med J, 49, 281
Becker A, 2003, Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, von Willebrand factor and (pro)insulin, Neth J Med, 61, 129
Knobl P, 1994, Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients, Thromb Haemost, 71, 692, 10.1055/s-0038-1642506
Fanghanel G, 1998, Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes, Rev Invest Clin, 50, 389
Schmeling A, 1996, Phenotype change in polymorphic plasma proteins following liver transplantation, Exp Clin Immunogenet, 13, 78
Gabriel D, 1992, The effect of fibrin structure on fibrinolysis, J Biol Chem, 267, 24259, 10.1016/S0021-9258(18)35759-4
Kroll M, 1989, Biochemical mechanisms of platelet activation, Blood, 74, 1181, 10.1182/blood.V74.4.1181.1181
Hangaishi M, 1997, Advanced glycation end products enhance the aggregation of human platelets in vitro, Circulation, 96, 665